IntroductionCystic fibrosis is an inherited disease that ultimately results in death. It affects all racial groups worldwide, but its prevalence varies from country to country. In people with cystic fibrosis, the lungs and digestive system are mainly affected by the disease. Thanks to new developments in treatment and management, the 50 percent survival rate of the 1970s has improved significantly, allowing patients to continue living their lives longer than ever before. New developments in exacerbation prevention, therapeutic drugs, and methods to preserve lung function have done great things to help patients prolong their lives. Education is another important aspect of CF treatment. For example, the more the patient knows about the disease and the benefits of treatment, the more likely they are to comply with the recommended treatment. Although treatment can be very expensive and time-consuming, it gives cystic fibrosis patients the opportunity to go to school, have a job, and even start a family. These are normal events that come with aging and that many CF patients could never dream of experiencing. PrevalenceCystic fibrosis is a recessive genetic disease. It is seen primarily in the Caucasian population, with 1 in 3,000 Caucasians having cystic fibrosis, but it affects all racial groups. According to the Cystic Fibrosis Foundation patient registry, in 2008 there were 30,000 cystic fibrosis patients in the United States. With this in mind, approximately 1,000 patients are newly diagnosed with cystic fibrosis each year. The Cystic Fibrosis Foundation also estimates that approximately 70,000 children and adults with cystic fibrosis suffer from...... middle of paper ......fibrosis. In (2011). ADAM Medical Encyclopedia ADAM, Inc. Retrieved from http://www.ncbi.nlm.nih.gov/pubmedhealth/PMH0001167/Clarithromycin therapy for patients with cystic fibrosis: a randomized controlled trial. Pediatr Pulmonol, Galli, F., Battistoni, A., Gambari, R., Pompella, A., Bragonzi, A., Pilolli, F., Iuliano, L., Piroddi, M., Dechecchi, MC, Cabrini, G .. Oxidative stress and antioxidant therapy in cystic fibrosis, Biochimica et Biophysica Acta (BBA) - Molecular bases of the diseaseDowman, JK, Watson, D., Loganathan, S., Gunson, BK, Hodson, J., Mirza, DF, Clarke, J., Lloyd C., Honeybourne D., Whitehouse, JL, Nash, E.F., Kelly, D., van Mourik, I., Newsome, PN. (2012). Long-term impact of liver transplantation on respiratory function and nutritional status of children and adults with cystic fibrosis. American Journal of Transplantation,